Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents

被引：29

作者：

Francis, Stuart ^{[1
]}

Croft, Daniel ^{[1
]}

Schtittelkopf, Alexander W. ^{[1
]}

Parry, Charles ^{[1
]}

Pughese, Angelo ^{[1
]}

Cameron, Ken ^{[1
]}

Claydon, Sophie ^{[1
]}

Drysdale, Martin ^{[1
,4
]}

Gardner, Claire ^{[1
]}

Gohlke, Andrea ^{[1
]}

Goodwin, Gillian ^{[1
]}

Gray, Christopher H. ^{[1
]}

Konczal, Jennifer ^{[1
]}

McDonald, Laura ^{[1
]}

Mezna, Mokdad ^{[1
]}

Pannifer, Andrew ^{[1
,5
]}

Paul, Nikki R. ^{[2
]}

Machesky, Laura ^{[2
,3
]}

McKinnon, Heather ^{[1
]}

Bower, Justin ^{[1
]}

机构：

[1] CRUK Beatson Inst, Drug Discovery Unit, Glasgow G61 1BD, Lanark, Scotland

[2] CRUK Beatson Inst, Cell Migrat Lab, Glasgow G61 1BD, Lanark, Scotland

[3] Univ Glasgow, Inst Canc Sci, Glasgow G61 1QH, Lanark, Scotland

[4] Broad Inst, Cambridge, MA 02142 USA

[5] Med Discovery Catapult, Alderly Pk, Alderley Edge SK10 4TG, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2019年 / 29卷 / 08期

关键词：

Virtual screening; Fragments; Drug discovery; Medicinal chemistry; Cancer; LIGAND; CANCER;

D O I：

10.1016/j.bmcl.2019.01.035

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Fascin is an actin binding and bundling protein that is not expressed in normal epithelial tissues but overexpressed in a variety of invasive epithelial tumors. It has a critical role in cancer cell metastasis by promoting cell migration and invasion. Here we report the crystal structures of fascin in complex with a series of novel and potent inhibitors. Structure-based elaboration of these compounds enabled the development of a series with nanomolar affinities for fascin, good physicochemical properties and the ability to inhibit fascin-mediated bundling of filamentous actin. These compounds provide promising starting points for fascin-targeted anti-metastatic therapies.

引用

页码：1023 / 1029

页数：7

共 50 条

[31] Structure-based design, synthesis and biological evaluation of novel dihydropyrones as potent HCV RNA polymerase inhibitors
Linton, Maria Angelica
Li, Hui
Tatlock, John H.
Gonzalez, Javier
Jewell, Tanya
Patel, Leena
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
[32] Structure-based design,synthesis,and biological evaluation of novel pyrimidinone derivatives as PDE9 inhibitors
Xu-Nian Wu
Ya-Dan Huang
Jin-Xuan Li
Yan-Fa Yu
Qian Zhou
Chen Zhang
Yinuo Wu
Hai-Bin Luo
ActaPharmaceuticaSinicaB, 2018, 8 (04) : 615 - 628
[33] Design, synthesis and biological evaluation of novel chromeno[4,3-c] pyrazol-4(2H)-one derivates containing sulfonamido as potential PI3Kα inhibitors
Yin, Yong
Hu, Jia-Qin
Wu, Xu
Sha, Shao
Wang, She-Feng
Qiao, Fang
Song, Zhong-Cheng
Zhu, Hai-Liang
BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (11) : 2261 - 2267
[34] Design, synthesis, molecular modeling and biological evaluation of novel 1H-pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents
Eissa, Ibrahim H.
El-Naggar, Abeer M.
El-Hashash, Maher A.
BIOORGANIC CHEMISTRY, 2016, 67 : 43 - 56
[35] A Novel Series of Acylhydrazones as Potential Anti-Candida Agents: Design, Synthesis, Biological Evaluation and In Silico Studies
Borcea, Anca-Maria
Marc, Gabriel
Ionut, Ioana
Vodnar, Dan C.
Vlase, Laurian
Gligor, Felicia
Pricopie, Andreea
Pirnau, Adrian
Tiperciuc, Brindusa
Oniga, Ovidiu
MOLECULES, 2019, 24 (01)
[36] Design, synthesis and biological evaluation of novel diphenylthiazole-based cyclooxygenase inhibitors as potential anticancer agents
Abdelazeem, Ahmed H.
Gouda, Ahmed M.
Omar, Hany A.
Tolba, Mai F.
BIOORGANIC CHEMISTRY, 2014, 57 : 132 - 141
[37] Structure-based hybridization, synthesis and biological evaluation of novel tetracyclic heterocyclic azathioxanthone analogues as potential antitumor agents
Chen, Tsung-Chih
Wu, Chia-Lun
Lee, Chia-Chung
Chen, Chun-Liang
Yu, Dah-Shyong
Huang, Hsu-Shan
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 103 : 615 - 627
[38] Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors
Tao, Zhi-Fu
Wang, Le
Stewart, Kent D.
Chen, Zehan
Gu, Wendy
Bui, Mai-Ha
Merta, Philip
Zhang, Haiying
Kovar, Peter
Johnson, Eric
Park, Chang
Judge, Russell
Rosenberg, Saul
Sowin, Thomas
Lin, Nan-Horng
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (07) : 1514 - 1527
[39] Design, Synthesis and Biological Evaluation of a Novel Series of Thiadiazole-Based Anticancer Agents as Potent Angiogenesis Inhibitors
Altug-Tasa, Burcugul
Kaya-cavusoglu, Betul
Koparal, Ayse T.
Turan, Gulhan
Koparal, Ali S.
Kaplancikli, Zafer A.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (15) : 2041 - 2049
[40] Structure-based design, synthesis, and biological evaluation of Leu-Arg dipeptide analogs as novel hepsin inhibitors
Kwon, Hongmok
Kim, YunHye
Park, Kieung
Choi, Soo An
Son, Sang-Hyun
Byun, Youngjoo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (02) : 310 - 314

← 1 2 3 4 5 →